The Course of Cognitive Impairment in Preclinical Alzheimer Disease
Open Access
- 1 June 2000
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 57 (6) , 839-844
- https://doi.org/10.1001/archneur.57.6.839
Abstract
IDENTIFYING INDIVIDUALS who are at increased risk of developing Alzheimer disease (AD) is currently a topic of great theoretical interest and practical importance.1,2 As more effective pharmacological therapies become available, the administration of these agents to individuals who are subtly impaired may render the treatments more effective.3Keywords
This publication has 8 references indexed in Scilit:
- Drug Treatments for Alzheimer??s DiseaseCNS Drugs, 1999
- A Prospective Study of Cognitive Function and Onset of Dementia in Cognitively Healthy EldersArchives of Neurology, 1998
- A 5-Year Longitudinal Study of the Mini-Mental State Examination in Normal AgingAmerican Journal of Epidemiology, 1997
- Activation of medial temporal structures during episodic memory retrievalNature, 1996
- The Mini‐Mental State Examination: A Comprehensive ReviewJournal of the American Geriatrics Society, 1992
- Development of dementing illnesses in an 80‐year‐old volunteer cohortAnnals of Neurology, 1989
- Cognitive Function and Prediction of Dementia in Old AgeInternational Journal of Aging & Human Development, 1987
- Empirical Power of Procedures for Comparing Two Groups on p VariablesJournal of Educational Statistics, 1982